Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumors.
Jimeno A, Baranda J, Iams WT, Park JC, Mita M, Gordon MS, Taylor M, Dhani N, Leal AD, Neupane P, Eng C, Yeku O, Mita A, Moser JC, Butler M, Loughhead SM, Jennings J, Miselis NR, Ji RR, Nair N, Kornacker M, Zwirtes RF, Bernstein H, Sharei A. Jimeno A, et al. Among authors: moser jc. Invest New Drugs. 2023 Apr;41(2):284-295. doi: 10.1007/s10637-023-01342-x. Epub 2023 Mar 3. Invest New Drugs. 2023. PMID: 36867316 Free PMC article. Clinical Trial.
Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases.
In GK, Ribeiro JR, Yin J, Xiu J, Bustos MA, Ito F, Chow F, Zada G, Hwang L, Salama AKS, Park SJ, Moser JC, Darabi S, Domingo-Musibay E, Ascierto ML, Margolin K, Lutzky J, Gibney GT, Atkins MB, Izar B, Hoon DSB, VanderWalde AM. In GK, et al. Among authors: moser jc. NPJ Precis Oncol. 2023 Nov 14;7(1):120. doi: 10.1038/s41698-023-00471-z. NPJ Precis Oncol. 2023. PMID: 37964004 Free PMC article.
Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data.
Moser JC, Bhatia S, Amin A, Pavlick AC, Betts KA, Du EX, Poretta T, Shelley K, Srinivasan S, Sakkal LA, Palaia J, Lobo M, Pe Benito M, Linton JA, Chen Y, Xu C, Yin L, Sundar M, Weber J. Moser JC, et al. Cancer Immunol Immunother. 2024 May 7;73(7):116. doi: 10.1007/s00262-024-03697-3. Cancer Immunol Immunother. 2024. PMID: 38713408 Free PMC article. Clinical Trial.
DNA mismatch repair deficiency in conjunctival melanoma.
Rodriguez A, Moser J, Ramasubramanian A. Rodriguez A, et al. Eye (Lond). 2023 Oct 6. doi: 10.1038/s41433-023-02733-3. Online ahead of print. Eye (Lond). 2023. PMID: 37803143 No abstract available.
Exploring the therapeutic potential of an antinociceptive and anti-inflammatory peptide from wasp venom.
Galante P, Campos GAA, Moser JCG, Martins DB, Dos Santos Cabrera MP, Rangel M, Coelho LC, Simon KS, Amado VM, de A I Muller J, Koehbach J, Lohman RJ, Cabot PJ, Vetter I, Craik DJ, Toffoli-Kadri MC, Monge-Fuentes V, Goulart JT, Schwartz EF, Silva LP, Bocca AL, Mortari MR. Galante P, et al. Among authors: moser jcg. Sci Rep. 2023 Aug 1;13(1):12491. doi: 10.1038/s41598-023-38828-w. Sci Rep. 2023. PMID: 37528129 Free PMC article.
The Mechanisms of Action of Tumor Treating Fields.
Moser JC, Salvador E, Deniz K, Swanson K, Tuszynski J, Carlson KW, Karanam NK, Patel CB, Story M, Lou E, Hagemann C. Moser JC, et al. Cancer Res. 2022 Oct 17;82(20):3650-3658. doi: 10.1158/0008-5472.CAN-22-0887. Cancer Res. 2022. PMID: 35839284 Free PMC article. Review.
41 results